Marta del Campo

Clinical value of neurofilament and phospho-tau/tau ratio in the frontotemporal dementia spectrum

Lieke Meeter, Everard G.B. Vijverberg, Marta del Campo et al. · Neurology · 2018 · 123 citations · Full text

CSF proteome profiling across the Alzheimer’s disease spectrum reflects the multifactorial nature of the disease and identifies specific biomarker panels

Marta del Campo, Carel F.W. Peeters, Erik C. B. Johnson et al. · Nature Aging · 2022 · 91 citations · Full text

Proteomic Technology, Neurodegenerative Diseases, Csf Proteome Profiling +12

CSF proteome profiling reveals biomarkers to discriminate dementia with Lewy bodies from Alzheimer´s disease

Marta del Campo, Lisa Vermunt, Carel F.W. Peeters et al. · Nature Communications · 2023 · 63 citations · Full text

Neurochemical Biomarkers, Neurobiology Of Disease, Neurology +20

Poly(GP), neurofilament and grey matter deficits in <i>C9orf72</i> expansion carriers

Lieke Meeter, Tania F. Gendron, Ana C. Sias et al. · Annals of Clinical and Translational Neurology · 2018 · 60 citations · Full text

BRI2-BRICHOS is increased in human amyloid plaques in early stages of Alzheimer's disease

Marta del Campo, Jeroen J.M. Hoozemans, Lois-Lee Dekkers et al. · Neurobiology of Aging · 2014 · 52 citations

Alzheimer's Disease, Human Amyloid Plaques, Biochemistry +8